Stryker (SYK) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Stryker (SYK) do?
Stryker Corp (SYK) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures and sells orthopedic implants, robotic arm assistance systems, surgical tools, and patient handling equipment. Supplies hospital systems directly with specialized joint implants, surgical instruments, and proprietary orthopedic. It is worth $119.19B on the market and sold $26.31B over the last year.
- Market cap
- $119.19B
- P/E ratio
- 33.4×
- Annual sales
- $26.31B
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 12, 2026
Brands and businesses behind SYK
- Mako: Sells robotic surgical platforms and procedure-specific consumables used by surgeons for knee and hip replacements.
- LIFEPAK: Produces automated external defibrillators and monitoring systems purchased by emergency medical teams and hospitals.
- Vocera: Provides hands-free wearable communication badges and software licenses to coordinate clinical hospital staff.
- Sage: Manufactures disposable oral care and skin hygiene products aimed at reducing hospital-acquired infections.
SYK’s flags, in plain English
Each flag is a number from Stryker’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 12, 2026.
Wide Gross Margin
Gross margin of 63.2% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Stupid Cash
Can pay this year's bills 2.2 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Fat Margins
Profit margin of 13.8%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.
Priced for Perfection
Priced at 33.4 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about SYK
How big is Stryker?
Stryker’s market cap is $119.19B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $26.31B: what customers paid the company over the last year, before any costs.
What is SYK’s P/E ratio?
SYK’s P/E ratio is 33.4×. Investors pay about 33.4 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with SYK?
Rigorous FDA regulations expose the business to product liability litigation and mandatory recalls across its implant and instrument lines. That is one risk on Stryker’s card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Stryker’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SYK’s filings on SEC.gov. The Margin Monkey is research, not advice.
